Open access journal of the Ferrata-Storti Foundation, a non-profit organization
Articles

Platelet glycoprotein VI and C-type lectin-like receptor 2 deficiency accelerates wound healing by impairing vascular integrity in mice

Institute of Cardiovascular Sciences, College of Medical and Dental Sciences, University of Birmingham, Birmingham, UK;Department of Pharmacology, Faculty of Pharmacy, Mahidol University, Bangkok, Thailand
Institute of Cardiovascular Sciences, College of Medical and Dental Sciences, University of Birmingham, Birmingham, UK
Institute of Cardiovascular Sciences, College of Medical and Dental Sciences, University of Birmingham, Birmingham, UK
Institute of Immunology and Immunotherapy, College of Medical and Dental Sciences, University of Birmingham, Birmingham, UK
Institute of Cardiovascular Sciences, College of Medical and Dental Sciences, University of Birmingham, Birmingham, UK
Centre of Membrane Proteins and Receptors (COMPARE), Universities of Birmingham and Nottingham, The Midlands, UK
Institute of Cardiovascular Sciences, College of Medical and Dental Sciences, University of Birmingham, Birmingham, UK
Institute of Cardiovascular Sciences, College of Medical and Dental Sciences, University of Birmingham, Birmingham, UK;Department of Pathophysiology, Sechenov First Moscow State Medical University, Moscow, Russia
Institute of Cardiovascular Sciences, College of Medical and Dental Sciences, University of Birmingham, Birmingham, UK;Centre of Membrane Proteins and Receptors (COMPARE), Universities of Birmingham and Nottingham, The Midlands, UK;Institute of Microbiology and Infection, College of Medical and Dental Sciences, University of Birmingham, Birmingham, UK
Institute of Cardiovascular Sciences, College of Medical and Dental Sciences, University of Birmingham, Birmingham, UK
Vol. 104 No. 8 (2019): August, 2019 https://doi.org/10.3324/haematol.2018.208363

Abstract

Platelets promote wound healing by forming a vascular plug and by secreting growth factors and cytokines. Glycoprotein (GP)VI and C-type lectin-like receptor (CLEC)-2 signal through a (hem)-immunoreceptor tyrosine-based activation motif, which induces platelet activation. GPVI and CLEC-2 support vascular integrity during inflammation in the skin through regulation of leukocyte migration and function, and by sealing sites of vascular damage. In this study, we investigated the role of impaired vascular integrity due to GPVI and/or CLEC-2 deficiency in wound repair using a full-thickness excisional skin wound model in mice. Transgenic mice deficient in both GPVI and CLEC-2 exhibited accelerated skin wound healing, despite a marked impairment in vascular integrity. The local and temporal bleeding in the skin led to greater plasma protein entry, including fibrinogen and clotting factors, was associated with increased fibrin generation, reduction in wound neutrophils and M1 macrophages, decreased level of tumor necrosis factor (TNF)-α, and enhanced angiogenesis at day 3 after injury. Accelerated wound healing was not due to developmental defects in CLEC-2 and GPVI double-deficient mice as similar results were observed in GPVI-deficient mice treated with a podoplanin-blocking antibody. The rate of wound healing was not altered in mice deficient in either GPVI or CLEC-2. Our results show that, contrary to defects in coagulation, bleeding following a loss of vascular integrity caused by platelet CLEC-2 and GPVI deficiency facilitates wound repair by increasing fibrin(ogen) deposition, reducing inflammation, and promoting angiogenesis.

Introduction

Cutaneous wound repair is a complex process, which requires a well-regulated interplay between diverse cell types and molecules.1 Four inter-related phases of wound healing have been described, namely hemostasis, inflammation, proliferation, and remodeling.1 Immediately upon injury, platelets and fibrin generate a hemostatic plug to prevent excessive blood loss. Additionally, the fibrin clot forms a scaffold to promote migration of local cells surrounding the wound.2 Deficiency in clotting factors, including tissue factor (TF), factor (F)VII or FIX, results in persistent intra-tissue bleeding and delayed wound healing.53 Shortly after, neutrophils and inflammatory macrophages (M1) are recruited to eliminate microbes and cellular debris, driving the inflammatory phase.61 During the proliferative phase, re-epithelialization and angiogenesis promote cell growth and wound recovery. In addition, fibroblasts infiltrate the granulation tissue to produce extracellular matrix proteins, and to differentiate into myofibroblasts, mediating wound contraction.1 In parallel, the number of M2 reparative macrophages increases, contributing to resolution of inflammation.61 Complete wound closure and re-organization of collagen fibers restore skin integrity during the remodeling phase.1

Platelets play several roles in wound healing during the hemostatic, inflammatory, and vascular repair phases.7 Platelets secrete chemoattractants and growth factors that mediate cell recruitment and tissue repair, respectively.871 This is illustrated by the delay in healing of corneal epithelial abrasion in thrombocytopenic and P-selectin-deficient mice.9 Moreover, platelet-rich plasma, which contains growth factors, promotes skin wound healing in mice10 and is a possible therapeutic agent to facilitate wound repair.

Platelet immunoreceptor tyrosine-based activation motif (ITAM) receptors, GPVI and CLEC-2, share a common Src/Syk/PLCγ2-dependent signaling pathway leading to platelet activation.11 A primary role for GPVI and a secondary role for CLEC-2 in maintaining vascular integrity in the inflamed skin has been demonstrated.1312 In addition, CLEC-2 and GPVI are key regulators of inflammation. GPVI promotes a pro-inflammatory phenotype during glomerulonephritis,14 arthritis,15 and dermatitis.16 The CLEC-2-podoplanin axis is anti-inflammatory and protects against organ damage during lung and systemic inflammation.1817

Due to the complex interplay between platelets and inflammation during wound healing, we hypothesize that GPVI and/or CLEC-2 regulate vascular integrity during wound repair and alter the healing process. In the present study, we show that deletion of both CLEC-2 and GPVI accelerates wound healing in a mouse model of full-thickness excisional skin wound repair. This is associated with a transient and self-limited bleeding (i.e. due to impaired vascular integrity), fibrin(ogen) matrix deposition, a reduction in wound neutrophils and M1 macrophages, and increased angiogenesis during the inflammatory phase. Taken together, we show that impaired vascular integrity-induced bleeding is beneficial during a model of sterile wound healing.

Methods

Animals

Male and female wild-type (WT), platelet-specific CLEC-2-deficient (Clec1bfl/flPf4-Cre), GPVI knockout (Gp6−/−), and CLEC-2/GPVI double-deficient (Clec1bfl/flPf4-Cre/Gp6−/−; DKO) mice aged 8-10 weeks were used. All experiments were performed in accordance with UK laws (Animal Scientific Procedures Act 1986) with the approval of the local ethics committee and UK Home Office under PPL P0E98D513 and P14D42F37, respectively.

Full-thickness excisional skin wound model

A single full-thickness excisional skin wound was made on the shaved flank skin of mice using a 4 mm-diameter biopsy punch (Kai Industries, Japan). Wounds were imaged using a Nikon COOLPIX B500 digital camera each day and wound size measured using calipers19 on a daily basis for up to nine days post injury. Wound area was calculated as described19 and presented as the percentage of initial wound size.10 In a second set of experiments, anti-podoplanin antibody (clone 8.1.1, 100 μg)201713 or IgG isotype control were intravenously injected 24 hours (h) before and again 24 h after wounding. Wound size was monitored for three days post injury.

Other associated methods

For details of other associated methods see the Online Supplementary Appendix.

Results

CLEC-2 and GPVI ligands are present within perivascular areas during skin wounding

In unchallenged WT mouse skin, collagen was abundantly expressed throughout the dermis and hypodermis, including around blood vessels, and podoplanin was predominantly expressed on lymphatic endothelial cells and on perivascular cells (Online Supplementary Figure S1A and B). At day 3 post wounding, podoplanin expression was also observed surrounding blood vessels in WT and transgenic mice (Figure 1A). These podoplanin-expressing cells included pericytes (neuron-glial antigen 2; NG2) (Figure 1A), fibroblasts (vimentin), infiltrating monocytes (Ly6C), and macrophages (F4/80) (Figure 1B). In addition, podoplanin was up-regulated on migrating keratinocytes, and on stromal and infiltrating cells within the granulation tissue (Online Supplementary Figure S1C). The level of perivascular podoplanin was increased in Clec1bfl/flPf4-cre mice compared to WT mice (Figure 1A and B). In DKO mice, podoplanin expression was similar to that observed in WT and Gp6−/− mice (Figure 1A and B).

Figure 1.Podoplanin-expressing cells are present at perivascular area in contact with platelets during skin wound repair. (A) Immunofluorescence staining of NG2 (red), podoplanin (green) and CD41 (white) illustrates platelets and podoplanin-expressing pericytes (NG2+) around blood vessel at day 3 after injury (n=5-7). Hoechst counterstains nuclei (blue). Arrow points to platelets at perivascular site. Star indicates extravascular localization of platelets. Scale bar=20 μm. (B) Podoplanin (green) was double-stained with either vimentin (red; top) or Ly6C (red; middle) or F4/80 (red; bottom), which are located around blood vessel (surrounded by NG2+ pericytes) at day 3 after injury (n=4-5). Scale bar=20 μm. BV: blood vessel.

Three days after wound injury, platelets (CD41) were observed in close proximity to the vessel wall (surrounded by pericytes) in WT, Clec1bfl/flPf4-cre, and Gp6−/− mice (Figure 1A, arrow). In DKO mice, platelets were more widely distributed, including at the vessel wall and in the surrounding tissue (Figure 1A, star). The platelet count in Clec1bfl/flPf4-cre and DKO mice was approximately 25% and 40% lower than in WT, respectively (Online Supplementary Figure S1D) and was not altered by wound injury.

These results demonstrate that platelets are present in perivascular areas during the initial wound healing process in mouse skin where the ligands for GPVI and CLEC-2 are also observed. Deletion of CLEC-2 from platelets is associated with increased podoplanin-expressing cells in the perivascular space during wound healing while concurrent ablation with GPVI reverses this phenotype.

Cutaneous wound healing is accelerated in mice deficient in platelet CLEC-2 and GPVI

To determine the contribution of platelet ITAM receptors in wound repair, we monitored the time course of wound closure in WT and platelet ITAM receptor(s)-deficient mice. All mouse strains exhibited complete wound closure within nine days post injury (Figure 2A). However, mice deficient in both GPVI and CLEC-2 demonstrated accelerated repair (Figure 2B), characterized by the presence of a dark scab and redness around the wound (Figure 2A), especially within the first three days after injury compared to WT and single ITAM-deficient mice. There was no discernible difference in wound appearance in any of the mouse strains after four days post injury (Figure 2A) and there was no difference in macroscopic wound size at day 9 post injury (Figure 2B). However, the morphometric analysis of skin histology at this time point revealed a significantly smaller scar in DKO mice, as shown by a shorter length of hyperplastic epidermis compared to WT and Clec1bfl/flPf4-cre mice (Figure 2C and D) and a narrower inter-subcutaneous gap than WT mice (Figure 2C and E).

Figure 2.Deletion of platelet immunoreceptor tyrosine-based activation motif (ITAM) receptors accelerates skin wound repair process. Mice were subjected to a full-thickness excisional skin wound and wound closure was monitored for nine days after injury. (A) Macroscopic appearance of wound at indicated time points. (B) Changes of wound size over nine days post injury (n=10-13). (C) Hematoxylin & Eosin staining at day 9 post-injury (n=9-13). a: length of hyperplastic epidermis; b: inter-subcutaneous distance. Scale bar=200 μm. (D) Measurement of the length of hyperplastic epidermis. (E) Measurement of inter-subcutaneous distance. All graphs are presented as mean±Standard Error of Mean (SEM). Kinetics of wound closure (B) are analyzed by two-way ANOVA with Bonferroni’s multiple comparison test. *P<0.05; **P<0.01. *WT versus DKO. +Clec1bfl/flPf4-cre versus DKO. #Gp6−/− versus DKO. Other parameters are analyzed by one-way ANOVA with Bonferroni’s multiple comparison test. *P<0.05.

At day 3 post injury, re-epithelialization was observed in all groups (Figure 3A). However, this process was enhanced in DKO mice compared to WT and Clec1bfl/flPf4-cre mice, but not Gp6−/− mice (Figure 3B). There was no significant difference in wound contraction between all tested groups (Figure 3C). DKO mice also had a larger area of granulation tissue compared to WT mice (Figure 3A and D). Improved wound healing was associated with enhanced angiogenesis as assessed by the increase in CD31 area in DKO animals at day 3 post injury (Figure 3E and F), although the density of blood vessels (CD31) and lymphatic vessels (podoplanin) in unchallenged skin was similar among all groups (Online Supplementary Figure S1E and F).

Figure 3.Enhanced re-epithelialization and angiogenesis occur at the early phase of wound healing in the absence of GPVI and CLEC-2. (A) Hematoxylin & Eosin staining at day 3 post-injury (n=6-9). Dotted line indicates hyperplastic coverages. Black arrow points to wound edge. Red arrow indicates gap between epithelial tongues. S: scab; G: granulation tissue. Scale bar=500 μm. (B) Measurement of re-epithelialization. (C) Measurement of wound contraction. (D) Quantification of granulation tissue area. (E) Detection of endothelial cells (CD31+ cells; green) in wound area at day 3 post injury. Hoechst counterstains nuclei (blue). Scale bar=50 μm. (F) Quantification of CD31+ area within the wound at day 3 post injury (n=5-6). Graphs are presented as mean±Standard Error of Mean and analyzed by one-way ANOVA with Bonferroni’s multiple comparison test. *P<0.05.

These results demonstrate that deletion of both CLEC-2 and GPVI accelerates skin wound closure, enhances re-epithelialization and angiogenesis, and reduces scar formation.

GPVI and CLEC-2 maintain vascular integrity during the inflammatory phase of wound repair

The redness surrounding the wound in DKO mice in the inflammatory phase is indicative of increased vascular leakiness. Macroscopic examination of the skin at day 3 post injury demonstrated vasodilation and bleeding into the wound as well as into the surrounding skin in DKO mice, with less severe vascular leakage seen in Gp6−/− mice (Figure 4A). Hematoxylin & Eosin (H&E) staining confirmed the extravasation of red blood cells (RBC) in the dermis at the edge of the wound at day 3 post injury in both DKO and Gp6−/− mice (Online Supplementary Figure S2A). Clearance of extravascular RBC was observed at day 9 post injury in all groups (Online Supplementary Figure S2B). Due to blood/lymphatic mixing phenotype in DKO, and to a lesser degree in Clec1bfl/flPf4-cre mice, RBC were also present in lymphatic vessels (podoplanin) (Online Supplementary Figure S2C).

Figure 4.Lack of platelet immunoreceptor tyrosine-based activation motif (ITAM) receptors causes local and temporal bleeding leading to fibrin(ogen) deposition during inflammatory phase of wound repair. (A) Macroscopic images of inner side of skin wound at day 3 post injury (n=4-6). Dotted circle indicates wound area. Arrow points to dilated vessel. Arrowhead shows bleeding into surrounding skin. (B) Fibrinogen staining (brown) of skin wound at day 3 post injury. (C) Quantification of fibrinogen content at day 3 post injury (n=6). (D) Martius scarlet blue (MSB) staining of skin wound at day 3 post-injury. Red: old fibrin; blue: collagen; yellow: red blood cells/fresh fibrin. (E) Quantification of fibrin content in the wound at day 3 post injury (n=6-9). (F) MSB staining of wound scar at day 9 post injury. (G) Quantification of fibrin content in the scar at day 9 post injury (n=9-13). Graphs are presented as mean±Standard Error of Mean and analyzed by one-way ANOVA with Bonferroni’s multiple comparison test. *P<0.05; **P<0.01. Scale bar=200 μm.

These observations demonstrate marked impairment of vascular integrity during the inflammatory phase of wound repair in DKO mice, with a milder phenotype in Gp6−/− mice. Vascular leakage is diminished in later phases when inflammation subsides.

GPVI and CLEC-2 deficiency increases fibrin(ogen) deposition during the inflammatory phase of repair

Increased vascular permeability results in leakage of blood cells and plasma proteins into the wound21 where they come in contact with TF,225 which activates the extrinsic pathway of blood coagulation. An increase in fibrinogen deposition was particularly marked in the granulation tissue at day 3 post injury (Figure 4B and C) with no significant alteration in TF expression in DKO mice (Online Supplementary Figure S3A and B). Fibrin con tent in the wound scab was similar between WT and DKO mice at day 1 post injury (Online Supplementary Figure S3C and D), but was significantly increased in the DKO mice at day 3 post injury, compared to WT and Clec1bfl/flPf4-cre mice but not to Gp6−/− mice, which exhibited a more moderate vascular leakage (Figure 4D and E). At day 9 post injury, fibrin was mainly located on the upper part of the scar in all groups (Figure 4F) and was notably lower in the DKO mice compared to WT and Gp6−/− mice (Figure 4G). There was no significant difference in wound (myo)fibroblasts (Online Supplementary Figure S3E-G) and collagen content (Online Supplementary Figure S3H and I) between DKO mice and WT at day 3 and day 9 post injury.

These results indicate that the loss of vascular integrity during the inflammatory phase increases extravasation of plasma proteins, including fibrinogen and clotting factors, into the wound of DKO mice. The increase in fibrinogen and fibrin deposition is associated with accelerated wound healing and is then cleared from the healing wound.

Platelet immunoreceptor tyrosine-based activation motif receptor deficiency reduces wound neutrophils and M1 macrophages during the inflammatory phase

The influx of inflammatory cells was investigated at days 1, 3, and 9 post injury. Neutrophil (Gr-1) infiltration on day 1 post injury was similar between WT and DKO mice (Online Supplementary Figure S4A and B). At day 3 post injury, DKO mice showed a significant impairment in neutrophil infiltration compared to WT and Clec1bfl/flPf4-cre mice but not Gp6−/− mice (Figure 5A and B). The decrease in neutrophil infiltration was confirmed using anti-Ly6G antibody clone 1A8 (data not shown). A 2-fold increase in wound neutrophils was observed in WT but not in DKO mice at this time relative to day 1 post injury (Figure 5C). At day 9 post injury, DKO mice showed higher numbers of wound neutrophils than WT (Figure 5D and E), although neutrophil level was significantly decreased in both groups relative to day 1 and day 3 post injury (Figure 5C). Blood neutrophil counts were similar in unchallenged mice across all groups (Figure 5F). At day 3 post injury, the number of blood neutrophils was significantly decreased in WT and Clec1bfl/flPf4-cre (Figure 5F) while remaining unaltered during the time course of wound healing in DKO and Gp6−/− mice (Figure 5F). The decrease in neutrophil infiltration was not due to a defect of chemoattractants at the wound site as measured by the presence of chemokine CXCL-1 (Online Supplementary Figure S6A and B) or platelet factor 4 (PF4) (Online Supplementary Figure S6C and D). In vitro migration towards N-formyl-methionyl-leucyl-phenylalanine (fMLP) using bone marrow-derived neutrophils demonstrated that migration of neutrophils from WT mice was attenuated by fibrinogen, and strongly inhibited by cross-linked fibrin compared to the migration through collagen (Online Supplementary Figure S7). Fibrinogen and fibrin showed a similar degree of inhibition for the migration of neutrophils from DKO mice (Online Supplementary Figure S7).

Figure 5.Neutrophil influx is decreased during the inflammatory phase of wound healing following platelet CLEC-2 and GPVI double-deletion. (A) Detection of neutrophils (Gr-1 staining; brown) in wound at day 3 post injury. (B) Quantification of neutrophils (Gr-1+ cells) in wound at day 3 post injury. *P<0.05; **P<0.01. (C) Comparison of Gr1+ cells between day 1, day 3, and day 9 post injury in wild-type (WT) and DKO mice. P<0.05 in *WT and §DKO mice, compared to the data at day 1 post injury, respectively. The bracket shows P<0.05 for the comparison between day 3 and day 9 post injury in *WT and §DKO mice, respectively. (D) Detection of neutrophils (Gr-1 staining; brown) in wound at day 9 post injury. (E) Quantification of neutrophils (Gr-1+ cells) in wound at day 9 post injury. *P<0.05. (F) Comparison of blood neutrophil counts between baseline, day 3, and day 9 post injury in each mouse strain. P<0.05 in *WT and +Clec1bfl/flPf4-cre mice, compared to their control, respectively. Sample numbers in unchallenged control = 10, day 1 = 5, day 3 = 6-9, and day 9 post injury = 9-13, respectively. Graphs are presented as mean±Standard Error of Mean and analyzed by one-way ANOVA with Bonferroni’s multiple comparison test. Scale bar = 20 μm.

There was no significant difference in wound monocytes (Ly6C) at day 1 post injury between DKO mice and WT (Online Supplementary Figure S4C and D). At day 3 post injury, DKO mice showed a significantly higher number of wound monocytes compared to all other strains (Figure 6A and B), which was reflected by a 4-fold increase in wound monocytes relative to day 1 post injury (Figure 6C). At day 9 post injury, monocytes within the wound remained at a low level in WT and single-knockout mice (Figure 6D and E). Wound monocytes in DKO mice were decreased at this time compared to day 3 post injury (Figure 6C), but remained higher than other groups (Figure 6D and E). In blood, Clec1bfl/flPf4-cre exhibited an increase in baseline circulating monocytes compared to WT and DKO mice (Online Supplementary Figure S4G, left). Blood monocytes were greatly reduced at day 3 and day 9 post injury in all groups compared to their unchallenged controls (Figure 6F). However, the level of blood monocytes in DKO mice was significantly higher than Clec1bfl/flPf4-cre mice at day 3 post injury (Online Supplementary Figure S4G, middle) and then all groups at day 9 post injury (Online Supplementary Figure S4G, right).

Figure 6.A higher number of wound monocytes is observed during the inflammatory phase of repair in mice that lack both GPVI and CLEC-2. (A) Detection of monocytes (Ly6C+ cells; brown) in wound at day 3 post-injury. (B) Quantification of Ly6C+ cells in wound at day 3 post-injury (n=5-7). **P<0.01. (C) Comparison of Ly6C+ cells between day 1, day 3, and day 9 post-injury in WT and DKO mice. The symbols * and § indicate P<0.05 in WT and DKO mice, compared to the data at day 1 post injury, respectively. The bracket shows P<0.05 for the comparison between day 3 and day 9 post injury in §DKO mice. (D) Detection of Ly6C+ cells (brown) in wound at day 9 post injury. (E) Quantification of Ly6C+ cells in wound at day 9 post injury (n=6). *P<0.05; **P<0.01. (F) Comparison of blood monocyte counts between baseline, day 3, and day 9 post injury in each mouse strain. The symbols *, +, #, and § indicate P<0.05 in WT, Clec1bfl/flPf4-cre, Gp6−/−, and DKO mice, compared to their control, respectively. Sample numbers in unchallenged control, n=10; day 1, n=5; day 3, n=6-9; day 9 post injury, n=10-13, respectively. Graphs are presented as mean±Standard Error of Mean and analyzed by one-way ANOVA with Bonferroni’s multiple comparison test. Scale bar = 20 μm.

The influx of macrophages (F4/80) in DKO mice was reduced at day 1 post injury compared to WT (Online Supplementary Figure S4E and F). At day 3 post injury, wound macrophages in Clec1bfl/flPf4-cre mice were elevated, compared to all other strains (Figure 7A and B). A 6-fold increase in wound macrophages was observed in WT mice at day 3 relative to day 1 post injury (Figure 7C). DKO mice showed a significant reduction in macrophages compared to WT but not Gp6−/− mice at this time (Figure 7B and C). Inducible nitric oxide synthase (iNOS)-expressing macrophages (M1 phenotype) (Figure 7D and E) and TNF-α level (Figure 7G and H) within the wound of DKO mice were decreased whereas Fizz-1-positive macrophages (a M2 marker) were similar to WT (Online Supplementary Figure S5D and E) at day 3 post injury. At day 9 post injury, wound macrophages in DKO mice were similar to WT and Clec1bfl/flPf4-cre mice (Online Supplementary Figure S5D and E) with no difference in M1 (Figure 7D and F) and M2 macrophages (Online Supplementary Figure S5A and C) between WT and DKO strains. Gp6−/− mice showed a lower number of macrophages within the wound scar than in Clec1bfl/flPf4-cre mice at day 9 post injury (Online Supplementary Figure S5E).

Figure 7.M1 macrophages and TNF-α level are reduced during the inflammatory phase of wound healing in platelet immunoreceptor tyrosine-based activation motif (ITAM) receptor-deficient mice. (A) Detection of macrophages (F4/80+ cells; brown) in wound at day 3 post injury. (B) Quantification of F4/80+ cells in wound at day 3 post injury (n=6-8). *P<0.05; **P<0.01. (C) Comparison of F4/80+ cells between day 1, day 3, and day 9 post injury in wild-type (WT) and DKO mice. The symbols * and § indicate P<0.05 in WT and DKO mice, compared to the data at day 1 post injury, respectively. The bracket shows P<0.05 for the comparison between day 3 and day 9 post injury in §DKO mice. Sample numbers at days post injury: at day 1, n=5; day 3, n=6-9; day 9, n=10-13, respectively. (D) Immunofluorescence double staining of iNOS (red) and F4/80 (green) in the wound of WT and DKO mice at day 3 (n=4) and day 9 (n=4) post injury. Hoechst counterstains nuclei (blue). (E) Quantification of M1 macrophages (iNOS+F4/80+ cells; yellow) at day 3 post injury (n=4). *P<0.05. (F) Quantification of M1 macrophages (iNOS+F4/80+ cells; yellow) at day 9 post injury (n=4). (G) Immunohistochemistry staining of TNF-α (brown) in the wound at day 3 post injury. (H) Quantification of TNF-α level in granulation tissue area at day 3 post injury (n=6). *P<0.05. Graphs are presented as mean±Standard Error of Mean and analyzed by either Student t-test (E, F) or one-way ANOVA with Bonferroni’s multiple comparison test (B, C, and H). Scale bar = 20 μm.

Overall, these data illustrate that CLEC-2 deletion promotes leukocyte sequestration in the wound during the inflammatory phase, especially macrophages. Deletion of both ITAM receptors leads to a significant reduction in wound neutrophils and M1 macrophages during this phase and a decrease in TNF-α expression in the tissue.

Inhibition of CLEC-2-podoplanin axis accelerates wound healing in GPVI-deficient mice

Clec1bfl/flPf4-cre and DKO mice present with blood/lymphatic mixing and moderate thrombocytopenia.1711 To investigate the influence of these defects on wound healing, we injected Gp6−/− mice with an antibody to podoplanin (anti-podoplanin-treated Gp6−/− mice) that blocks CLEC-2-podoplanin interaction. A significant acceleration in wound healing was observed in anti-podoplanin-treated Gp6−/− mice at day 2 and day 3 post injury (Figure 8A and B), in association with enhanced vascular leakage (Figure 8A and C) and increased fibrin deposition (Figure 8D and E). Moreover, decreased wound neutrophils (Figure 8F and G) and macrophages (Figure 8H and I), and higher wound monocytes (Online Supplementary Figure S8A and B) but unaltered level of TNF-α (Online Supplementary Figure S8C and D) were observed in anti-podoplanin-treated Gp6−/− mice. The re-epithelialization (Online Supplementary Figure S8E and F), granulation tissue formation (Online Supplementary Figure S8E and H), and angiogenesis (Online Supplementary Figure S8I and J) were also increased in anti-podoplanin-treated Gp6−/− mice. However, no significant change was seen in wound contraction (Online Supplementary Figure S8E and G). Similar to DKO mice, extravasation of platelets was detected together with the presence of anti-podoplanin antibody on pericytes and other perivascular cells in anti-podoplanin-treated Gp6−/− mice at this time (Online Supplementary Figure S9).

Figure 8.Anti-podoplanin antibody injection in Gp6−/− mice (Gp6−/− + anti-PDPN) simulates the accelerated phenotype of skin wound repair observed in DKO mice. (A) Macroscopic appearance of wound at indicated time points. Arrow points to intra-skin bleeding around the wound at day 3 post injury. (B) Changes of wound size over 3 days post injury (n=5). (C) Hematoxylin & Eosin staining at day 3 post-injury (n=5). Arrow points the bleeding into surrounding skin. Scale bar = 20 μm. (D) Martius scarlet blue staining of skin wound at day 3 post injury. Red: old fibrin, blue: collagen, yellow: red blood cells/fresh fibrin. Scale bar = 200 μm. (E) Quantification of fibrin content (red) in the wound at day 3 post injury (n=5). (F) Staining of neutrophils (Gr-1; brown) in wound area at day 3 post injury. (G) Quantification of neutrophils (Gr-1+ cells) in wound area at day 3 post injury (n=5). (H) Detection of macrophages (F4/80 staining; brown) in wound area at day 3 post injury. (I) Quantification of macrophages (F4/80+ cells) in wound area at day 3 post-injury (n=5). All graphs are presented as mean±Standard Error of Mean. Kinetics of wound closure (B) are analyzed by two-way ANOVA with Bonferroni’s multiple comparison test. Other parameters are analyzed by Student t-test. *P<0.05.

These data indicate that the accelerated wound healing in DKO mice is not due to developmental defects or thrombocytopenia, but due to a combined loss of the interaction of platelet CLEC-2 and GPVI with their respective ligands.

Discussion

In this study, we show that combined deletion of platelet CLEC-2 and GPVI promotes healing of a full-thickness skin wound in mice compared to WT or single-knockout mice. The accelerated wound closure is accompanied by impairment of vascular integrity, rapid re-epithelialization and an increase in granulation tissue formation, resulting in a smaller wound scar. This is also associated with elevated levels of fibrinogen and fibrin in the tissue, reduced infiltration of leukocytes, and enhanced angiogenesis. A proposed model for the multi-factorial regulation of accelerated wound healing in the absence of the two ITAM receptors is shown in Online Supplementary Figure S10.

Wound healing is a multistep process involving coagulation, vascular permeability changes, inflammation, cell proliferation, and cell migration.2121 In our study, we show that deletion of CLEC-2 and GPVI in platelets leads to increased bleeding into the wound, in association with accelerated wound repair. These effects are not due to blood/lymphatic vessel mixing or the reduction in platelet count in the DKO mice as similar results were observed in anti-podoplanin-antibody treated Gp6−/− mice, which do not have these defects. Acceleration of wound healing is also observed in mice treated with histamine23 or serum fraction of the natural latex from rubber tree,21 which enhances vascular permeability, a milder form of vascular leakage. Therefore, impaired vascular integrity as seen in the DKO platelets or increased permeability leads to extravasation of growth factors, cytokines, and plasma proteins to the tissue, and promotion of wound healing.

The role of blood coagulation in wound repair has been studied in mice expressing low TF5 or lacking FIX (hemophilia B mice).53 In these two models, the deficiency in clotting factors leads to a persistent hematoma formation (due to a prolonged subcutaneous bleeding) and a reduction in fibrin generation, both of which contribute to a delay in wound repair. Chronic hemorrhage also con tributes to the characteristics of non-healing wounds in cancers, which promote tumor growth.2624 In contrast, we show that in the presence of an intact coagulation cascade, the transient and self-limited bleeding into the wound (which is rich in TF225) caused by the impairment of vascular integrity at an initial stage, is associated with accelerated wound repair. This is most likely due to increased entry of platelets, clotting factors, and plasma proteins, leading to fibrinogen accumulation and fibrin generation. Thus, the mechanism of bleeding determines whether it is beneficial or detrimental to wound repair.

Fibrinogen and fibrin are not only crucial for clot formation, but also act as a natural suture/sealant, providing a matrix for cell migration as well as a reservoir for growth factors and cytokines.2 For example, fibrin exposes plasminogen to migrating keratinocytes, which in turn convert plasminogen into plasmin to mediate fibrinolysis, allowing the cells to move along the fibrin(ogen) matrix.2927 Similarly, endothelial cells proliferate and migrate over fibrin(ogen), forming a capillary tube that contributes to angiogenesis during wound healing.3230 In DKO mice, we therefore propose that fibrin(ogen) accumulation promotes re-epithelialization and angiogenesis, and accelerates wound repair.

In contrast, fibrinogen33 and a high concentration of fibrin34 inhibit neutrophil migration as previously reported and in line with our in vitro data. These data may explain our observations that in DKO mice, wound neutrophils at day 3 did not increase over the amount seen at day 1 post injury. This is in contrast to wound neutrophil accumulation in WT, which was higher at day 3 than at day 1 post injury. Increased fibrin content in the wound was also observed in DKO mice compared to WT at day 3 post injury. Therefore, the physical obstruction and anti-migratory properties of the fibrin clot is likely to inhibit neutrophil wound entry observed in DKO mice. Moreover, given that, at this early phase, there was no significant difference in the level of blood neutrophils between WT and DKO mice, altered neutrophil turnover/apoptosis in DKO mice is unlikely to make a significant contribution to the reduction in wound neutrophils observed in DKO compared to WT at day 3 post injury.

Consistent with our data, several lines of evidence demonstrate improved wound healing in neutrophil-depleted conditions.3835 Indeed, neutrophil infiltration mediates damage through a production of proteases,35 oxidative radicals, elastase,39 and neutrophil extracellular traps,37 all of which can delay the healing process. A similar effect of fibrin(ogen) might also apply to monocyte/macrophage recruitment since fibrinogen has an anti-adhesive effect against monocytes.40 A recent sterile wound model has demonstrated that Ly6C monocytes are present throughout wound healing and differentiate into M1 macrophages during inflammatory phase and M2 macrophages during the reparative phase.41 In addition, it has been shown that TNF-α secretion is increased during monocyte-to-M1-macrophage differentiation.4241 The reduction in TNF-α during the inflammatory phase is associated with the increase in wound monocytes but not macrophages. This suggests an inhibition in monocyte-to-M1-macrophage transition in DKO mice, resulting in a significant change in immune cell infiltration in the wound.

Depletion of macrophages in the first five days has previously been shown to delay the later stages of wound closure, but not during the inflammatory phase (day 1-3).43 This is due to a decrease in M2 macrophages,43 supporting our observation that a reduction in wound macrophages, particularly M1 phenotype, in the early phase does not negatively affect wound closure but may contribute to the reduction in scar formation.43 The alteration in M2 macrophages was not observed in DKO mice although the previous dermatitis model has reported an increase number of M2 phenotypes in GPVI-deficient mice,16 suggesting other contributing factors for macrophage polarization during skin wound healing.6

The increased risk of wound contamination is a concern in the context of intra-tissue bleeding and reduced wound leukocytes. However, it has recently been shown that rapid formation of a fibrin film over the surface of the wound is protective against bacterial infection.44 This process might also reduce the need for leukocyte infiltration to kill microbes. Moreover, a previous study has reported that a 2-fold increase in wound neutrophils is driven by Staphylococcus aureus infection.45 Whether the beneficial potential of targeting GPVI and CLEC-2 might modulate the risk of wound infection requires further investigation.

In conclusion, we show that deletion of platelet GPVI and CLEC-2 facilitates cutaneous wound repair through a local and temporal vascular leakage leading to increased fibrin(ogen) deposition and reduced leukocyte infiltration. Thus, impaired vascular integrity due to the loss of GPVI and CLEC-2 is beneficial to wound repair. This contrasts with results in coagulation-deficient mice, with differences explained by altered formation of fibrin and most likely alteration in immune cell trafficking. A shorter duration of healing lowers the risk of complications (e.g. infection) and the cost of caring for the wound.46 Based on our study, targeting CLEC-2 and GPVI at the wound site together with optimal wound care (e.g. aseptic dressing) might represent a new pathway to promote healing and reduce scar formation.

Acknowledgments

The authors would like to thank the BMSU at the University of Birmingham for technical support in animal experiments and the Technology Hub for imaging assistance.

Footnotes

  • Check the online version for the most updated information on this article, online supplements, and information on authorship & disclosures: www.haematologica.org/content/104/8/1648
  • FundingThis work was supported by the Ministry of Sciences and Technology of Thailand and the British Heart Foundation (RG/13/18/30563). SPW holds a BHF Chair (CH03/003).
  • Received October 12, 2018.
  • Accepted January 28, 2019.

References

  1. Shaw TJ, Martin P. Wound repair at a glance. J Cell Sci. 2009; 122(Pt 18):3209-3213. PubMedhttps://doi.org/10.1242/jcs.031187Google Scholar
  2. Drew AF, Liu H, Davidson JM, Daugherty CC, Degen JL. Wound-healing defects in mice lacking fibrinogen. Blood. 2001; 97(12):3691-3698. PubMedhttps://doi.org/10.1182/blood.V97.12.3691Google Scholar
  3. Hoffman M, Harger A, Lenkowski A, Hedner U, Roberts HR, Monroe DM. Cutaneous wound healing is impaired in hemophilia B. Blood. 2006; 108(9):3053-3060. PubMedhttps://doi.org/10.1182/blood-2006-05-020495Google Scholar
  4. Xu Z, Xu H, Ploplis VA, Castellino FJ. Factor VII deficiency impairs cutaneous wound healing in mice. Mol Med. 2010; 16(5-6):167-176. PubMedGoogle Scholar
  5. Monroe DM, Mackman N, Hoffman M. Wound healing in hemophilia B mice and low tissue factor mice. Thromb Res. 2010; 125(Suppl 1):S74-77. PubMedhttps://doi.org/10.1016/j.thromres.2010.01.043Google Scholar
  6. Sindrilaru A, Scharffetter-Kochanek K. Disclosure of the Culprits: Macrophages-Versatile Regulators of Wound Healing. Adv Wound Care (New Rochelle). 2013; 2(7):357-368. PubMedhttps://doi.org/10.1089/wound.2012.0407Google Scholar
  7. Golebiewska EM, Poole AW. Platelet secretion: From haemostasis to wound healing and beyond. Blood Rev. 2015; 29(3):153-162. PubMedhttps://doi.org/10.1016/j.blre.2014.10.003Google Scholar
  8. Brill A, Elinav H, Varon D. Differential role of platelet granular mediators in angiogenesis. Cardiovasc Res. 2004; 63(2):226-235. PubMedhttps://doi.org/10.1016/j.cardiores.2004.04.012Google Scholar
  9. Li Z, Rumbaut RE, Burns AR, Smith CW. Platelet response to corneal abrasion is necessary for acute inflammation and efficient re-epithelialization. Invest Ophthalmol Vis Sci. 2006; 47(11):4794-4802. PubMedhttps://doi.org/10.1167/iovs.06-0381Google Scholar
  10. Yang HS, Shin J, Bhang SH. Enhanced skin wound healing by a sustained release of growth factors contained in platelet-rich plasma. Exp Mol Med. 2011; 43(11):622-629. PubMedhttps://doi.org/10.3858/emm.2011.43.11.070Google Scholar
  11. Bender M, May F, Lorenz V. Arterioscler Thromb Vasc Biol. 2013; 33(5):926-934. PubMedhttps://doi.org/10.1161/ATVBAHA.112.300672Google Scholar
  12. Gros A, Syvannarath V, Lamrani L. Single platelets seal neutrophil-induced vascular breaches via GPVI during immune-complex-mediated inflammation in mice. Blood. 2015; 126(8):1017-1026. PubMedhttps://doi.org/10.1182/blood-2014-12-617159Google Scholar
  13. Rayes J, Jadoui S, Lax S. The contribution of platelet glycoprotein receptors to inflammatory bleeding prevention is stimulus and organ dependent. Haematologica. 2018; 103(6):e256-e258. PubMedhttps://doi.org/10.3324/haematol.2017.182162Google Scholar
  14. Devi S, Kuligowski MP, Kwan RY. Platelet recruitment to the inflamed glomerulus occurs via an alphaIIbbeta3/GPVI-dependent pathway. Am J Pathol. 2010; 177(3):1131-1142. PubMedhttps://doi.org/10.2353/ajpath.2010.091143Google Scholar
  15. Boilard E, Nigrovic PA, Larabee K. Platelets amplify inflammation in arthritis via collagen-dependent microparticle production. Science. 2010; 327(5965):580-583. PubMedhttps://doi.org/10.1126/science.1181928Google Scholar
  16. Pierre S, Linke B, Suo J. GPVI and Thromboxane Receptor on Platelets Promote Proinflammatory Macrophage Phenotypes during Cutaneous Inflammation. J Invest Dermatol. 2017; 137(3):686-695. PubMedhttps://doi.org/10.1016/j.jid.2016.09.036Google Scholar
  17. Rayes J, Lax S, Wichaiyo S. The podoplanin-CLEC-2 axis inhibits inflammation in sepsis. Nat Commun. 2017; 8(1):2239. https://doi.org/10.1038/s41467-017-02402-6Google Scholar
  18. Lax S, Rayes J, Wichaiyo S. Platelet CLEC-2 protects against lung injury via effects of its ligand podoplanin on inflammatory alveolar macrophages in the mouse. Am J Physiol Lung Cell Mol Physiol. 2017; 313(6):L1016-L1029. PubMedhttps://doi.org/10.1152/ajplung.00023.2017Google Scholar
  19. Moreira CF, Cassini-Vieira P, da Silva MF, Barcelos LS. Skin Wound Healing Model -Excisional Wounding and Assessment of Lesion Area. Bio-protocol. 2015; 5(22):e1661. Google Scholar
  20. Payne H, Ponomaryov T, Watson SP, Brill A. Mice with a deficiency in CLEC-2 are protected against deep vein thrombosis. Blood. 2017; 129(14):2013-2020. PubMedhttps://doi.org/10.1182/blood-2016-09-742999Google Scholar
  21. Mendonca RJ, Mauricio VB, Teixeira Lde B, Lachat JJ, Coutinho-Netto J. Increased vascular permeability, angiogenesis and wound healing induced by the serum of natural latex of the rubber tree Hevea brasiliensis. Phytother Res. 2010; 24(5):764-768. PubMedGoogle Scholar
  22. Chen J, Kasper M, Heck T. Tissue factor as a link between wounding and tissue repair. Diabetes. 2005; 54(7):2143-2154. PubMedhttps://doi.org/10.2337/diabetes.54.7.2143Google Scholar
  23. Numata Y, Terui T, Okuyama R. The accelerating effect of histamine on the cutaneous wound-healing process through the action of basic fibroblast growth factor. J Invest Dermatol. 2006; 126(6):1403-1409. PubMedhttps://doi.org/10.1038/sj.jid.5700253Google Scholar
  24. McDonald DM, Baluk P. Significance of blood vessel leakiness in cancer. Cancer Res. 2002; 62(18):5381-5385. PubMedGoogle Scholar
  25. Dvorak HF. Tumors: wounds that do not heal-redux. Cancer Immunol Res. 2015; 3(1):1-11. PubMedhttps://doi.org/10.1158/2326-6066.CIR-14-0209Google Scholar
  26. Yin T, He S, Liu X. Extravascular red blood cells and hemoglobin promote tumor growth and therapeutic resistance as endogenous danger signals. J Immunol. 2015; 194(1):429-437. PubMedhttps://doi.org/10.4049/jimmunol.1400643Google Scholar
  27. Kubo M, Van de Water L, Plantefaber LC. Fibrinogen and fibrin are anti-adhesive for keratinocytes: a mechanism for fibrin eschar slough during wound repair. J Invest Dermatol. 2001; 117(6):1369-1381. PubMedhttps://doi.org/10.1046/j.0022-202x.2001.01551.xGoogle Scholar
  28. Ronfard V, Barrandon Y. Migration of keratinocytes through tunnels of digested fibrin. Proc Natl Acad Sci U S A. 2001; 98(8):4504-4509. PubMedhttps://doi.org/10.1073/pnas.071631698Google Scholar
  29. Geer DJ, Andreadis ST. A novel role of fibrin in epidermal healing: plasminogen-mediated migration and selective detachment of differentiated keratinocytes. J Invest Dermatol. 2003; 121(5):1210-1216. PubMedhttps://doi.org/10.1046/j.1523-1747.2003.12512.xGoogle Scholar
  30. Chalupowicz DG, Chowdhury ZA, Bach TL, Barsigian C, Martinez J. Fibrin II induces endothelial cell capillary tube formation. J Cell Biol. 1995; 130(1):207-215. PubMedhttps://doi.org/10.1083/jcb.130.1.207Google Scholar
  31. Laurens N, Koolwijk P, de Maat MP. Fibrin structure and wound healing. J Thromb Haemost. 2006; 4(5):932-939. PubMedhttps://doi.org/10.1111/j.1538-7836.2006.01861.xGoogle Scholar
  32. Sahni A, Francis CW. Vascular endothelial growth factor binds to fibrinogen and fibrin and stimulates endothelial cell proliferation. Blood. 2000; 96(12):3772-3778. PubMedGoogle Scholar
  33. Higazi AA, Barghouti II, Ayesh SK, Mayer M, Matzner Y. Inhibition of neutrophil activation by fibrinogen. Inflammation. 1994; 18(5):525-535. PubMedGoogle Scholar
  34. Hanson AJ, Quinn MT. Effect of fibrin sealant composition on human neutrophil chemotaxis. J Biomed Mater Res. 2002; 61(3):474-481. PubMedhttps://doi.org/10.1002/jbm.10196Google Scholar
  35. Dovi JV, He LK, DiPietro LA. Accelerated wound closure in neutrophil-depleted mice. J Leukoc Biol. 2003; 73(4):448-455. PubMedhttps://doi.org/10.1189/jlb.0802406Google Scholar
  36. Mori R, Kondo T, Ohshima T, Ishida Y, Mukaida N. Accelerated wound healing in tumor necrosis factor receptor p55-deficient mice with reduced leukocyte infiltration. FASEB J. 2002; 16(9):963-974. PubMedhttps://doi.org/10.1096/fj.01-0776comGoogle Scholar
  37. Wong SL, Demers M, Martinod K. Diabetes primes neutrophils to undergo NETosis, which impairs wound healing. Nat Med. 2015; 21(7):815-819. PubMedhttps://doi.org/10.1038/nm.3887Google Scholar
  38. Stavrou EX, Fang C, Bane KL. Factor XII and uPAR upregulate neutrophil functions to influence wound healing. J Clin Invest. 2018; 128(3):944-959. https://doi.org/10.1172/JCI92880Google Scholar
  39. Wilgus TA, Roy S, McDaniel JC. Neutrophils and Wound Repair: Positive Actions and Negative Reactions. Adv Wound Care (New Rochelle). 2013; 2(7):379-388. PubMedhttps://doi.org/10.1089/wound.2012.0383Google Scholar
  40. Lishko VK, Burke T, Ugarova T. Antiadhesive effect of fibrinogen: a safeguard for thrombus stability. Blood. 2007; 109(4):1541-1549. PubMedhttps://doi.org/10.1182/blood-2006-05-022764Google Scholar
  41. Crane MJ, Daley JM, van Houtte O, Brancato SK, Henry WL, Albina JE. The monocyte to macrophage transition in the murine sterile wound. PLoS One. 2014; 9(1):e86660. PubMedhttps://doi.org/10.1371/journal.pone.0086660Google Scholar
  42. Francke A, Herold J, Weinert S, Strasser RH, Braun-Dullaeus RC. Generation of mature murine monocytes from heterogeneous bone marrow and description of their properties. J Histochem Cytochem. 2011; 59(9):813-825. PubMedhttps://doi.org/10.1369/0022155411416007Google Scholar
  43. Lucas T, Waisman A, Ranjan R. Differential roles of macrophages in diverse phases of skin repair. J Immunol. 2010; 184(7):3964-3977. PubMedhttps://doi.org/10.4049/jimmunol.0903356Google Scholar
  44. Macrae FL, Duval C, Papareddy P. A fibrin biofilm covers blood clots and protects from microbial invasion. J Clin Invest. 2018; 128(8):3356-3368. Google Scholar
  45. Kim MH, Liu W, Borjesson DL. Dynamics of neutrophil infiltration during cutaneous wound healing and infection using fluorescence imaging. J Invest Dermatol. 2008; 128(7):1812-1820. PubMedhttps://doi.org/10.1038/sj.jid.5701223Google Scholar
  46. Lindholm C, Searle R. Wound management for the 21st century: combining effectiveness and efficiency. Int Wound J. 2016; 13(Suppl 2):5-15. Google Scholar

Article Information

Vol. 104 No. 8 (2019): August, 2019 : Articles
 
DOI
https://doi.org/10.3324/haematol.2018.208363
Pubmed
30733265
Pubmed Central
PMC6669159
 
Published
2019-08-01
Published By
Ferrata Storti Foundation, Pavia, Italy
Print ISSN
0390-6078
Online ISSN
1592-8721
 

Article Usage

Online Views
1544
PDF Downloads
594

Statistics from Altmetric.com

No Data
Navigate
For Authors
For Reviewers
For Advertisers
Education
Privacy
More
Copyright © 2024 by the Ferrata Storti Foundation | Web design ￫ | Development ￫
ISSN 0390-6078 print | ISSN 1592-8721 online